Response Pharmaceuticals
PrivateLast Round
Series B
Apr 23, 2024
Total Funding Raised
$8M
Company Overview
Response Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for weight management and metabolic health, with a lead candidate, RDX-002, being evaluated for antipsychotic-induced weight gain and post-GLP-1 weight management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Response Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Response Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 23, 2024 | ||||
| Series A | Nov 21, 2022 |
Response Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | Series A |
| Transhuman Capital | Series A |
| CrossWork | Series A |
Response Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Response Pharmaceuticals's valuation, stock price, and market status.
